The Wall Street Journal: Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment [MarketWatch]
Adamis Pharmaceuticals Corporation (ADMP)
Last adamis pharmaceuticals corporation earnings: 11/12 04:16 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.adamispharmaceuticals.com/investor-overview
Company Research
Source: MarketWatch
Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment Adamis Pharmaceuticals Corp. said the U.S. Food and Drug Administration has accepted for review its New Drug Application for a naloxone injection product used to treat opioid overdoses. The FDA provided a target agency action date of Oct. 31. Adamis shares ADMP, +0.36% traded up 6% after hours to $2.99. Naloxone, widely used to fight overdoses, is sold as Narcan in nasal spray form. Narcan was developed by Opiant Pharmaceuticals Inc. (OPNT) and licensed to Adapt Pharma. Adapt was sold to Emergent BioSolutions Inc. (EBS) in an October deal that included $635 million of cash and stock upfront. Adamis, which has called its naloxone injection a higher dose product, noted in February that an article in the journal Substance Abuse Treatment, Prevention, and Policy said higher doses could be a “simple countermeasure” amid more abuse of synthetic opioids like fentanyl. The FDA has called for increased
Show less
Read more
Impact Snapshot
Event Time:
ADMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMP alerts
High impacting Adamis Pharmaceuticals Corporation news events
Weekly update
A roundup of the hottest topics